Glomerulonephritis

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

TESTING -ON Post-Trial ObservatioNal Cohort Study

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy

ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Bortezomib for Treating Glomerular Diseases

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria